[artículo] 
inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - PP. 32-38

Título :	Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder
Tipo de documento:	texto impreso
Autores:	Joel Raskin, Autor ; Curtis G. Wiltse, Autor ; James J. Dinkel, Autor
Fecha de publicación:	2023
Artículo en la página:	PP. 32-38
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antidepresivos, Trastorno depresivo mayor, Tiofenos - administración y dosificación
Resumen:	To compare the safety and tolerability profile of duloxetine versus placebo in elderly (≥65 years) patients with major depressive disorder (MDD). Patients were randomized (2:1) to duloxetine 60 mg/d (once daily) (n = 207) or placebo (n = 104) for 8 weeks. Safety and tolerability measures were analyzed in the total cohort of patients, as well as in subgroups defined by age and preexisting hypertension.
Link:	./index.php?lvl=notice_display&id=30870

[artículo] Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder [texto impreso] / Joel Raskin, Autor ; Curtis G. Wiltse, Autor ; James J. Dinkel, Autor . - 2023 . - PP. 32-38.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - PP. 32-38

Palabras clave:	Antidepresivos, Trastorno depresivo mayor, Tiofenos - administración y dosificación
Resumen:	To compare the safety and tolerability profile of duloxetine versus placebo in elderly (≥65 years) patients with major depressive disorder (MDD). Patients were randomized (2:1) to duloxetine 60 mg/d (once daily) (n = 207) or placebo (n = 104) for 8 weeks. Safety and tolerability measures were analyzed in the total cohort of patients, as well as in subgroups defined by age and preexisting hypertension.
Link:	./index.php?lvl=notice_display&id=30870